The cellular slime mold Dictyostelium discoideum is normally susceptible to the action of the polyene antibiotic nystatin. We describe conditions under which transient nystatin resistance can be induced in the absence of detectable changes in sterol composition. These results suggest that nystatin plays a positive role in promoting resistance to itself.
The cellular slime mold Dictyostelium discoideum is normally susceptible to the action of the polyene antibiotic nystatin. We describe conditions under which transient nystatin resistance can be induced in the absence of detectable changes in sterol composition. These results suggest that nystatin plays a positive role in promoting resistance to itself.
Nystatin is a polyene antibiotic that has been widely used as an antifungal agent since its discovery in 1950 (6) . Beginning with the work of Gottlieb and his co-workers (4), a large body of evidence has accumulated that suggests that the primary mode of action of polyene antibiotics depends on their binding of membrane sterols, although the overall state of membrane lipid organization may also be important (1, 8) . Azasterol A25822B (a generous gift of Eli Lilly & Co., Indianapolis, Ind.) is an experimental antimycotic antibiotic that has been shown to interfere with sterol biosynthesis (2, 5, 14) . By studying the growth properties of Dictyostelium amoebae in the presence of azasterol and nystatin, we found evidence that nystatin can promote resistance to itself.
Dictyostelium amoebae grew on nutrient agar plates containing azasterol up to a concentration of 30 ,ug/ml. At 15 ,ug of azasterol per ml, the amoebae showed a 65% efficiency of plating (EOP). When amoebae grown at this concentration were transferred to plates containing 100 ,ug of nystatin per ml, (nyslOO), they grew with an EOP of 8.7 x 10-2 (Table 1) .
This was a striking and unexpected result, because amoebae grown on normal medium and then transferred to nyslOO plates give an EOP that is 4 orders of magnitude lower (11) . In fact, the EOP on nystatin for the azasterol-grown amoebae was only 2 to 4 times lower than that associated with true nystatin-resistant mutants (11) . As long as the amoebae were grown on nystatin plates, they maintained their nystatin resistance. When the nystatin-resistant amoebae were transferred to normal plates, allowed 10 to 15 generations of growth, and then transferred back to nyslOO plates, the EOP fell to i0-5 (Table 1) . Ten to fifteen generations should be taken as an upper limit; the minimum time necessary for loss of induction is being determined. It is clear, however, that nystatin resistance is transient and that its maintenance is dependent on the presence of nystatin.
In constructing models to explain these results, we first needed to explain how growth on azasterol conferred resistance to nystatin. In the yeast Saccharomyces cerevisiae, growth on subinhibitory concentrations of azasterol results in the replacement of ergosterol, the normal sterol, by ignosterol, a sterol that does not occur in nature (5) . Azasterol blocks the reduction of the A14 unsaturation that follows the C-14 demethylation of lanosterol (2) . If the same mechanism of action occurs in D. discoidum, we would expect azasterol-grown amoebae to produce another sterol in place of the wild-type sterol stigmastenol (7) . If that sterol is unable to bind nystatin or binds it poorly, we would expect azasterol-grown cells to be resistant to nystatin. In an * Corresponding author.
analogous experiment, Sud and Feingold (13) showed that ketoconazole-treated Candida cells become resistant to amphotericin B as ergosterol is replaced by other sterols.
In the present study, we performed sterol analysis as follows. Amoebae of the wild-type strain DdB were harvested and washed in water to remove bacteria. Each gram (wet weight) of amoebae was homogenized first with 10 ml of reagent-grade methanol and then with the addition of 20 ml of reagent-grade chloroform. After vacuum filtration, the filtrate was washed with a 1/4 volume of 0.88% aqueous KCI, and the bottom layer was washed again with a 1/4 volume methanol-water (1:1 [vol/vol]). The bottom layer was evaporated to dryness and dissolved in high-pressure liquid chromatography-grade hexane.
Gas chromatography was done on a Varian chromatograph (model 3700) with a DB1701 fused silica capillary column (30 m by 0.25 mm) at 260°C. Cholesterol was used as an internal standard.
Sterol analysis of azasterol-grown amoebae (Table 2 ) indicated that stigmastenol was, indeed, replaced by a new sterol. The identity of the sterol is as yet undetermined.
It is less straightforward to explain why nystatin resistance persists. When azasterol-grown yeast cells are transferred back to normal plates, ergosterol synthesis is restored (5) . If stigmastenol synthesis is restored after transfer of the Dictyostelium amoebae from azasterol to nystatin (aza-+nys) plates, we would expect the cells to become susceptible to nystatin as stigmastenol replaces the unnatural sterol. We analyzed the sterols in aza-*nysl00 cells, and we determined that stigmastenol biosynthesis was, indeed, restored ( Table 2 ). The main sterol of these cells had the same retention time and molecular weight as that of the wild type, DdB, which we previously showed to be stigmastenol (11) . These cells, then, were nystatin resistant despite having normal sterols, and they required nystatin for the maintenance of that resistance. We propose that nystatin is capable of inducing its own resistance.
In a previous paper (9), we described a class of transient nystatin-resistant cells that arise with a frequency of approximately 10-5 when wild-type amoebae are plated on nysl00 plates. We believe that the occurrence of those low-frequency transients is related to the phenomenon described here and that it can be connected by the following model. When wild-type amoebae were plated directly on nysl00 plates, the amoebae were rapidly killed by the interaction of the drug with the membrane sterol. However, at a low frequency (-10-5) a cell will survive long enough for the proposed positive action (induction) by nystatin to take effect, making the cell nystatin resistant. long as it is maintained on nystatin. These would appear as our previously described transient nystatin-resistant cells (9) . If wild-type amoebae are first grown on azasterol and then transferred to nystatin, a much higher percentage (.10-1) will survive the initial nystatin killing as a result of the replacement of stigmastenol by the unnatural sterol, and most of these cells will then be made transiently nystatin resistant by the secondary action of nystatin to promote its own resistance.
Our model suggests that the basis of nystatin resistance in azasterol-grown amoebae is different from the mechanism of resistance in aza--nys-transferred amoebae. In a previous study (11) , we observed that the spores of some nystatin-resistant mutants could germinate on plates containing nystatin, whereas spores of other mutants could not. We allowed both azasterol-grown amoebae and aza-inys100-transferred amoebae to form spores and then plated them on nyslOO plates. The spores from azasterol-grown amoebae germinated on nystatin, whereas spores from the aza-*nyslOOtransferred amoebae could not (Table 1) . This difference supports our model.
If nystatin induces its own resistance, it might be possible to see some induction with subinhibitory concentrations of nystatin. That is, nystatin might induce under conditions in which it did not kill. Wild-type amoebae were grown on plates containing 30 ,ug of nystatin per ml (nys30), where they gave an EOP of 0.67. Those amoebae were then transferred to nyslOO plates, and they showed a 3-order-ofmagnitude increase in EOP when compared with the controls (Table 1 ). These cells also showed the same transient nystatin resistance and dependence previously described for the aza-*nys-transferred cells. Self-induced drug resistance has been described in procaryotes for a number of different antibiotics, including penicillin, tetracycline, erythromycin, and chloramphenicol (3). The mechanisms by which induction can be achieved are quite variable but include (i) induction of an inactivating enzyme, (ii) induction of an alteration in the drug binding site resulting in reduced affinity, and (iii) induction of a permeability change resulting in reduced uptake. In addition, two mechanisms related to the specific effects of nystatin can be suggested. In one, nystatin can cause a reduction in the transport of sterol to the plasma membrane, and in the other, nystatin can induce a change in a membrane component resulting in the reduction of pore formation (10) by the nystatin-sterol complex. Experiments are currently in progress to determine the mechanism of induction. In eucaryotes, transient drug resistance has often been associated with gene amplification (12) . Although we cannot rule this out completely, we believe it to be unlikely in this case because there was no selection involved in the induction phenomenon. It will be of interest to determine whether the phenomenon described here is unique to D. discoideum or is also found in other organisms. The Candida experiments (13) in which ketoconazole promoted amphotericin resistance were not done in a way that permitted determination of whether the resistance could persist in the absence of ketoconazole. It will also be of interest to determine whether this phenomenon can be extended to other polyene antibiotics.
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